Read full coverage from Cannabis Business Times, MMJ Daily, Politico Pro, and Cannabis Wire.

NCR\’s Executive Director Saphira Galoob, Director of Policy David Mangone, and Director of Communications and Policy Advisor Erin Moffet sat down with Karson Humiston for an interview for an episode of the Vangst podcast, \”Proud to Work in Cannabis.\” You can find this here, or wherever you listen to podcasts.

Several organizations and cannabis companies sent statements to High Times. The National Cannabis Roundtable (NCR) applauded the historic acknowledgement that a federal agency has recommended cannabis be reclassified. The NCR announced that they have been instrumental in advocating for and informing the heads of the HHS in a memo, and the DEA in an open letter, as to the scientific […]

“The importance of a federal agency publicly acknowledging that cannabis is inappropriately classified as a Schedule I substance and has accepted medical use cannot be overstated,” said Saphira Galoob, Executive Director of the National Cannabis Roundtable, in a press release.   Read full coverage here.

Read coverage here.

Multiple media outlets covered NCR\’s inaugural Corporate Social Responsibility Report, which highlights NCR members commitments to address issues including health disparities and criminal justice reform. Coverage can be found at outlets including: Benzinga, Financial Post, Global Newswire, Cannabis Wire, Politico, and Marijuana Moment.

“We thank Congressman Blumenauer for his years of service as a champion for federal cannabis reform & addressing the harms of the War on Drugs. His congressional leadership cannot be replaced, but we will all continue to work to carry his critical work on the Hill forward.”   Read full text here.

Listen here or anywhere you get podcasts.

NCR Executive Director Saphira Galoob moderated this panel at Benzinga Chicago, featuring Senator Cory Gardner, Representative Ed Perlmutter and Reginald Babin. Watch the full panel here.

NCR Director of Policy David Mangone moderated this panel at Benzinga Chicago, featuring Norman Birenbaum and Patrick Cournoyer of the FDA. Watch the full panel here.